Get the Stockscreener App
11.28
2.55%
0.28
After Hours:
11.28
Envveno Medical Corporation stock is traded at $11.28, with a volume of 1,000.
It is up +2.55% in the last 24 hours and up +6.31% over the past month.
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
See More
Previous Close:
$11.00
Open:
$10.94
24h Volume:
1,000
Relative Volume:
0.05
Market Cap:
$7.39M
Revenue:
-
Net Income/Loss:
$-19.47M
P/E Ratio:
-0.4419
EPS:
-25.5243
Net Cash Flow:
$-15.57M
1W Performance:
+3.01%
1M Performance:
+6.31%
6M Performance:
-58.84%
1Y Performance:
-86.23%
1-Day Range:
$10.94
$11.28
1-Week Range:
$10.73
$11.65
52-Week Range:
$8.67
$196.70
Envveno Medical Corporation Stock (NVNO) Company Profile
Name
Envveno Medical Corporation
Sector
Industry
Phone
949-261-2900
Address
70 DOPPLER, IRVINE
Compare NVNO vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corporation
|
11.28 | 7.21M | 0 | -19.47M | -15.57M | -25.52 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Envveno Medical Corporation Stock (NVNO) Latest News
What is enVVeno Medical Corporations market position2026 Price Swings & AI Driven Stock Movement Reports - baoquankhu1.vn
enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System - The Florida Times-Union
Stop Loss: What is enVVeno Medical Corporations market positionQuarterly Market Review & Technical Entry and Exit Alerts - baoquankhu1.vn
Whats the profit margin of enVVeno Medical Corporation2026 Market Mood & Risk Managed Investment Signals - baoquankhu1.vn
NVNO PE Ratio & Valuation, Is NVNO Overvalued - Intellectia AI
enVVeno Medical Shares Crash After FDA Reaffirms VenoValve Rejection - MSN
Dow Update: Is enVVeno Medical Corporation a strong candidate for buy and holdMarket Trend Report & Consistent Profit Alerts - baoquankhu1.vn
Market Wrap: Whats the MACD signal for enVVeno Medical Corporation2026 Short Interest & Daily Profit Maximizing Tips - baoquankhu1.vn
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - The News-Star
enVVeno Medical Corp (NVNO) SEC filings - GuruFocus
enVVeno Medical Corp (NVNO) Stock Earnings Transcripts - GuruFocus
enVVeno Medical Reports FY GAAP EPS of -$33.06 Amid Reverse Stock Split - Intellectia AI
Market Pulse: Whats the MACD signal for enVVeno Medical Corporation2026 Technical Patterns & Weekly Top Gainers Alerts - baoquankhu1.vn
AI Models Reiterate High-Risk, Speculative View on enVVeno Medical (NVNO) - TipRanks
enVVeno Medical reports FY25 EPS ($33.06) vs. ($44.53) last year - TipRanks
EnVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of EnVVe(R) System - 富途牛牛
[10-K] enVVeno Medical Corp Files Annual Report - Stock Titan
enVVeno Medical 10-K: Net loss $19.5M, no revenue, EPS not disclosed - TradingView
5HJ0 Stock Price and Chart — FWB:5HJ0 - TradingView
If You Invested $1,000 in Envveno Medical Corporation (NVNO) - Stock Titan
NVNO's Shares Decline on Unfavorable FDA Review Outcome for VenoValve - MSN
Insider Sell: Francis Duhay Sells Shares of enVVeno Medical Corp (NVNO) - GuruFocus
[144] enVVeno Medical Corp SEC Filing - Stock Titan
Volatility Watch: Is enVVeno Medical Corporation a strong candidate for buy and hold2026 Spike Watch & Safe Capital Preservation Plans - baoquankhu1.vn
enVVeno Medical (NVNO) Stock Analysis Report | Financials & Insights - Benzinga Japan
NorthStrive Fund II LP Calls on enVVeno Medical to Halt Clinical Spending Plans and Call Special Shareholder Meeting to Vote on Strategic Alternatives - The Manila Times
Reviewing Pressure BioSciences (OTCMKTS:PBIO) & enVVeno Medical (NASDAQ:NVNO) - Defense World
NVNO SEC FilingsEnvveno Medical Corporation 10-K, 10-Q, 8-K Forms - Stock Titan
NVNO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Can enVVeno Medical Corporation maintain sales growthQuarterly Profit Summary & Daily Growth Stock Tips - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
enVVeno Medical (NVNO) investor urges halt to trials, strategic review - Stock Titan
enVVeno Medical Announces Reverse Stock Split - Press & Sun-Bulletin
Perceptive funds hold 2.05M enVVeno (NVNO) shares and warrants - Stock Titan
Envveno Medical Corporation Stock (NVNO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.40%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):